Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss RxSight Q1 2026 Earnings EPS Misses Estimates by 32 as Operational Costs Weigh ADCT Q1 2026 Earnings EPS Beat Amid Revenue Absence DQ Q1 2026 Earnings Polysilicon Price Pressures Drive Historic EPS Miss High Tide Inc Q1 2026 Earnings EPS Surges Past Estimates by 300 Federal Signal Corporation FSS Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency